 This study found that urinary potasin is a potential biomarker for detecting early signs of diabetic kidney disease, DKD, in type 2 diabetes mellitus, T2DM, patients. The results suggest that urinary potasin may serve as a useful tool for monitoring the progression of DKD in T2DM patients. This article was authored by Abdelbasid al-Sharawee, Maha Abdelmanian Bihari, Somia Abdelhamid Bawadi and others.